EU drug regulators said Tuesday that a vaccine specifically adapted for the new Omicron coronavirus variant could be approved in 3-4 months, if needed.
However, the decision on whether a new shot is needed needs to be made by another agency, said Emer Cooke, Executive Secretary of the European Medicines Agency.
“If we need to change an existing vaccine, we may be able to get approval within three to four months,” Cook told the European Parliament Commission.
“It’s from the beginning when they start to change.”
Her comment comes after the head of US vaccine maker Moderna said the existing jab would fight a heavily mutated Omicron.
Moderna has already stated that it is working on Omicron-specific vaccines, as well as its US rival Pfizer.
Cook said EU regulators still “do not know if the current vaccine will continue to be effective against Omicron (it will take about two weeks to discover) or if a new vaccine is needed. “.
“You have to first decide if you need it, but it’s not the European Medicines Agency’s decision,” Cook said.
The agency has so far approved four vaccines for adults in the EU. Pfizer-BioNTech, Moderna, AstraZeneca, Johnson & Johnson.
According to Cook, a one-fifth decision by US company Novabax is expected to be made “within a few weeks.”
Read all the latest news, latest news, coronavirus news here.
Omicron vaccine can nod in 4 months: EU watchdog
Source link Omicron vaccine can nod in 4 months: EU watchdog